ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

Immunogenicity and Safety of the COVID-19 Messenger RNA Vaccine Coadministered With Influenza and 23-valent Pneumococcal Polysaccharide Vaccines.

Omid Rezahosseini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.